HERO-Together: A post-Emergency Use Authorization observational cohort study to evaluate the safety of the Pfizer-BioNTech COVID-19 vaccine in US healthcare workers, their families, and their communities

First published 17/12/2020

Last updated 23/04/2024

EU PAS number:

EUPAS38671

Study

Finalised

Documents

Study protocol

Initial protocol

C4591008 v1 16Dec2020 Non-Interventional Post Authorization Safety Study (PASS) Protocol

English (1.26 MB - PDF)View document

Updated protocol

C4591008_PROTOCOL AMENDMENT 3_17AUG2023

First published: 22/02/2024

English (648.39 KB - PDF)View document

Study results

C4591008_ABSTRACT AND FINAL REPORT FOR EU PAS_30NOV2023

English (6.3 MB - PDF)View document

Study report

Other information

Study, other information

C4591008_PROTOCOL AMENDMENT 2_20APR2021

English (3.17 MB - PDF)View document

Secondary tabs